Extracorporeal membrane oxygenation with lepirudin anticoagulation for Wegener's granulomatosis with heparin-induced thrombocytopenia

ASAIO Journal

Volumn 51, Issue 4, 2005, Pages 477-479

  Balasubramanian, Sendhil K ^a,b   Tiruvoipati, Ravindranath ^a   Chatterjee, Shimonti ^a   Sosnowski, Andrew ^a   Firmin, Richard K ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CARDIOLOGY; COAGULATION; HEMODYNAMICS; MEDICAL PROBLEMS; OXYGEN; PATIENT TREATMENT;

ANTICOAGULATION; CARDIAC ARREST; CARDIOVASCULAR INSTABILITY; EXTRACORPOREAL MEMBRANE OXYGENATION;

CARDIOVASCULAR SYSTEM;

CYCLOPHOSPHAMIDE; HEPARIN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; LEPIRUDIN; PREDNISOLONE;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CASE REPORT; CORRELATION ANALYSIS; EXTRACORPOREAL OXYGENATION; HEPARINIZATION; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; THROMBOCYTOPENIA; WEGENER GRANULOMATOSIS;

ANTICOAGULANTS; EXTRACORPOREAL MEMBRANE OXYGENATION; HEPARIN; HIRUDINS; HUMANS; LUNG; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RESPIRATORY DISTRESS SYNDROME, ADULT; THROMBOCYTOPENIA; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 23044451400     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000169123.21946.31     Document Type: Article

References (12)

1. Peek GJ, Hillary M, Moore N, et al: Extracorporeal membrane oxygenation for adult respiratory failure. Chest 112: 759-764, 1997.
2. Linden V, Palmer K, Reinhard J, et al: High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 26: 1630-1637, 2000.
3. Chong BH: Heparin-induced thrombocytopenia. Br J Haematol 89: 431-439, 1995.
4. Greinacher A, Volpel H, Janssens U, et al: Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study. Circulation 99: 73-80, 1999.
5. Langford CA, Huffman GS: Wegener's granulomatosis. Thorax 54: 629-637, 1999.
6. Hartmann A, Nordal KP, Svennevig J, et al: Successful use of artificial lung (ECMO) and kidney in the treatment of a 20-year-old female with Wegener's syndrome. Neprol Dial Transplant 9: 316-319, 1994.
7. Green RJ, Ruoss SJ, Kraft SA, et al: Pulmonary capillaritis and alveolar hemorrhage: Update on diagnosis and management. Chest 110: 1305-1316, 1996.
8. Deitcher SR, Topoulos AP, Bartholomew JR, et al: Lepirudin anticoagulation for heparin-induced thrombocytopenia. J Pediatr 140: 264-266, 2002.
9. Koster A, Hansen R, Kuppe H, et al: Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients. J Cardiothorac Vasc Anesth 14: 243-248, 2000.
10. Koza MJ, Walenga JM, Fareed J, et al: A new approach in monitoring recombinant hirudin during cardiopulmonary bypass. Sem Thromb Hemost 19: 90-96, 1993.
11. Potzsch B, Madiener K, Seelig C, et al: Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass-Assessment of the whole blood ecarin clotting time. Thromb Hemost 77: 920-925, 1997.
12. Koster A, Merkle F, Hansen R, et al: Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: Assessment of different filter systems. Anesth Analg 91: 265-269, 2000.